Key Findings on GLP-1 Use in MS
GLP-1 receptor agonists (e.g., Ozempic, Wegovy) show potential in multiple sclerosis (MS) as potential neuroprotective, anti-inflammatory, and weight-loss agents. Preclinical studies…
Mediterranean diet and risk of multiple sclerosis: A prospective cohort study
Abstract Background and Objectives: Although adherence to the Mediterranean diet has been reported to be inversely associated with risk of…
Stuart Schlossman
Exercise and Cognition in Multiple Sclerosis in 2025: Forward Momentum or Going Nowhere Fast?
Abstract Purpose of Review There is increasing interest in the study of exercise training as an approach to treat the…
Stuart Schlossman
Role of vitamin D as adjuvant therapy on multiple sclerosis:
Role of vitamin D as adjuvant therapy on multiple sclerosis: an updated systematic review and meta-analysis of randomized controlled trials…
Stuart Schlossman
video: Living Well with MS plus the Impact of Lifestyle Choices and more
Event date: July 26, 2025 — Presented by: Chris LaGanke, MD-MS Neurologist at Joanne P. LaGanke MS Center in Cullman,…
Stuart Schlossman
Learning about Occupational Therapy in MS
Presented by: Karen Hislop, OTR, ARP, CDRS, CLT Topics: What is Occupational Therapy? Learn about neuroplasticity and neurorehabilitation devices, the…
Stuart Schlossman
Pelvic floor training
Do you have bowel, bladder and/or sexual problems? Here, I discuss pelvic floor exercises, which may help alleviate all these…
Stuart Schlossman
The latest research in exercise for MS with Dr Robert Motl
An Overcoming MS – Living Well Podcast…
Stuart Schlossman
HAPPY FEET, HEALTHIER YOU
May 2025 By: Mindy Eisenberg, MHSA, C-IAYT, ERYT-500 with Bettyanne Hodges, Director of Marketing, YMMS To learn more about Mindy…
Stuart Schlossman
A LOOK at Holistic & Mainstream Approaches to Multiple Sclerosis
No excerpt…
Stuart Schlossman
